Zonghong Shao Selected Research

RNA (Ribonucleic Acid)

1/2024	Single-cell RNA sequencing reveals abnormal transcriptome signature of erythroid progenitors in pure red cell aplasia.
11/2022	Single-cell RNA sequencing identifies the properties of myelodysplastic syndrome stem cells.
8/2021	Aberrant microRNA expression in B lymphocytes from patients with primary warm autoimmune haemolytic anaemia.
1/2015	HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zonghong Shao Research Topics

Disease

20	Aplastic Anemia (Anemia, Hypoplastic) 04/2022 - 11/2002
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2023 - 01/2013
12	Neoplasms (Cancer) 01/2022 - 04/2014
10	Pancytopenia 01/2022 - 05/2002
8	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 12/2023 - 01/2013
8	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 02/2022 - 02/2002
8	Cytopenia 01/2022 - 01/2013
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023 - 05/2015
7	Hemolysis 12/2023 - 02/2002
7	Multiple Myeloma 10/2023 - 07/2014
7	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 02/2018
6	Infections 09/2021 - 01/2014
4	Pure Red-Cell Aplasia 02/2024 - 10/2018
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 02/2017
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2014
4	Hematologic Diseases (Blood Diseases) 10/2020 - 03/2002
3	Thrombosis (Thrombus) 01/2022 - 12/2008
3	Mycoses (Diseases, Fungus) 07/2021 - 09/2017
3	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 09/2017
3	Iron Overload 01/2020 - 08/2017
3	Virus Diseases (Viral Diseases) 01/2020 - 12/2016
2	Anemia 02/2022 - 09/2014
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
2	Invasive Fungal Infections 07/2021 - 07/2018
2	Hypertension (High Blood Pressure) 03/2021 - 06/2019
2	Evans Syndrome 10/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 07/2015
2	Bone Marrow Failure Disorders 01/2019 - 01/2013
2	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 01/2017
2	Bone Diseases (Bone Disease) 11/2015 - 01/2014
1	Body Weight (Weight, Body) 12/2023
1	Jaundice (Icterus) 06/2023
1	Drug-Related Side Effects and Adverse Reactions 12/2022
1	Hemorrhage 07/2022
1	Purpura 07/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022

Drug/Important Bio-Agent (IBA)

11	AutoantibodiesIBA 01/2022 - 01/2013
7	Inosine Triphosphate (ITP)IBA 12/2023 - 05/2015
7	Messenger RNA (mRNA)IBA 12/2023 - 11/2002
7	CytokinesIBA 11/2020 - 11/2002
6	AntibodiesIBA 12/2023 - 11/2002
6	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 01/2015
6	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
5	Hemoglobins (Hemoglobin)IBA 12/2023 - 12/2008
5	Complement System Proteins (Complement)IBA 01/2021 - 02/2002
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2015
4	IronIBA 12/2023 - 09/2014
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 02/2002
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 05/2002
4	Decitabine FDA Link 01/2023 - 11/2015
4	Rituximab (Mabthera)FDA Link 01/2021 - 10/2016
3	AutoantigensIBA 01/2022 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2016
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2020 - 01/2014
3	Immunoglobulin M (IgM)IBA 06/2019 - 01/2015
3	Hormones (Hormone)IBA 01/2013 - 03/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2024 - 09/2021
2	MicroRNAs (MicroRNA)IBA 12/2023 - 08/2021
2	Long Noncoding RNAIBA 12/2023 - 01/2015
2	HepcidinsIBA 12/2023 - 09/2014
2	romiplostim FDA Link 07/2023 - 12/2022
2	BilirubinIBA 06/2023 - 06/2018
2	Histones (Histone)IBA 04/2022 - 11/2016
2	ApoferritinsIBA 01/2022 - 01/2020
2	Interleukin-12 (IL 12)IBA 11/2020 - 02/2018
2	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2019
2	Immunoglobulin A (IgA)IBA 10/2020 - 01/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2020 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2017
2	PerforinIBA 01/2020 - 12/2016
2	MucinsIBA 01/2020 - 12/2016
2	Granzymes (Granzyme)IBA 01/2020 - 12/2016
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 12/2019 - 03/2016
2	Caspofungin (Cancidas)FDA Link 07/2018 - 09/2017
2	Complement C3 (C3 Complement)IBA 06/2018 - 11/2002
2	Small Interfering RNA (siRNA)IBA 04/2018 - 01/2015
2	Formaldehyde (Formol)FDA Link 06/2017 - 04/2014
2	ParaffinIBA 06/2017 - 04/2014
2	Tigecycline (Tygacil)FDA Link 09/2014 - 01/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2002 - 02/2002
1	venetoclaxIBA 12/2023
1	Azacitidine (5 Azacytidine)FDA Link 12/2023
1	Competitive Endogenous RNAIBA 12/2023
1	Heme (Haem)IBA 12/2023
1	Thalidomide (Thalomid)FDA Link 10/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 04/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2022
1	COVID-19 VaccinesIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	zimberelimabIBA 01/2022

Therapy/Procedure

14	Therapeutics 01/2023 - 01/2014
4	Drug Therapy (Chemotherapy) 02/2022 - 03/2002
2	Induction Chemotherapy 07/2020 - 02/2017
2	Aftercare (After-Treatment) 11/2015 - 07/2015
1	Blood Transfusion (Blood Transfusions) 02/2022
1	Combination Drug Therapy (Combination Chemotherapy) 02/2022